Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News PharmaMar’s lurbinectedin granted orphan drug designation by FDA for small cell lung cancer treatment Spanish pharmaceutical company PharmaMar has announced that its cancer drug, lurbinectedin, has received orphan drug designation from the… bypharmanewsdailyAugust 5, 2018